Industry

Global Analyzer Market to Reach USD 16.0 Billion by 2025
The global market for clinical chemistry analyzers is expected to reach USD 16.0 billion by 2025, driven by their increased adoption due to the growing prevalence of chronic diseases, fueled further by an increasing geriatric and bariatric population, which is highly susceptible to chronic diseases. The resulting high sample volume requiring high capability analyzing devices will drive the growth of the global clinical chemistry analyzers market, going forward. More...31 Mar 2017
Streck Enters Distribution Agreement with Dow Biomedica
Streck, Inc., which develops and manufactures products for clinical and research laboratories, has entered into a distribution agreement for its cell stabilization, molecular and flow cytometry products with Dow Biomedica, a distributor of diagnostic products specializing in immunology, microbiology and QC materials. More...31 Mar 2017
Greiner Bio-One to Serve Spain and Portugal through Distribution Subsidiaries
Greiner Bio-One has acquired its long-standing distribution partners, VacuetteEspaña and Vacuette Portugal, which will now allow the medical technology company to serve its customers in Spain and Portugal directly through its own distribution subsidiaries. More...28 Mar 2017
POCT Market Reaches USD 18 Billion in 2016
Sales of point of care (POC) diagnostic testing, both professional testing and self-testing, reached USD 18.4 billion in 2016, driven by emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices that aim to provide expedited diagnosis where the patient is seen or in the patient’s home. These new technologies are allowing POC devices to generate quantitative lab-quality test results and transfer them automatically to an information system, a remote caregiver service for consultation or an electronic medical record. More...10 Mar 2017
Collaboration Improves Diagnosis and Monitoring of Multiple Myeloma
The Binding Site Group Ltd. has entered into a collaboration agreement with Mayo Clinic to develop a clinical laboratory test for the identification and accurate measurement of monoclonal proteins present in B-cell diseases. Both the organizations have been involved in collaborative activities for more than two decades with the aim of improving the testing, diagnosis and monitoring of patients with multiple myeloma and related conditions. The output of the latest collaboration will build on combining The Binding Site’s antibody- and assay-development expertise with Mayo Clinic’s clinical excellence and its recently patented approach to improving multiple myeloma patient monitoring. More...10 Mar 2017
Molecular Diagnostics Market Worth Nearly USD 7 Billion
The size of the molecular diagnostic testing market has reached USD 6.7 billion and is being driven by the growing threat of infectious disease and cancer, as well as the development of new products. These are the latest findings of Kalorama Information, an independent medical market research firm. More...21 Feb 2017

Siemens Healthineers Commissioned to Provide Lab Services for Turkish Hospitals
Siemens Healthineers has entered into a five-year contract to take over the clinical laboratory service operations for two new hospitals in Turkey. The hospitals in Bilkent, Ankara, and in Mersin are being built and operated as Public Private Partnership (PPP) by DiA Construction, a subsidiary of DiA, for the Turkish Ministry of Health. More...09 Feb 2017
In Other News
Streck Enters into Distribution Agreement with HiSS Diagnostics
Werfen and Instrumentation Laboratory Acquire Accriva Diagnostics
PerkinElmer Acquires Indian IVD Firm Tulip Diagnostics
Qiagen Acquires Bioinformatics Firm OmicSoft
Agilent Technologies to Acquire Multiplicom
Top Five In Vitro Diagnostic Trends of 2016
Siemens Healthineers to Invest USD 300 Million in Massachusetts Facility Expansion
Hologic to Sell Blood-Screening Business to Grifols for USD 1.85 Billion
Abbott Seeks to Terminate Alere Acquisition
Immunoassay Products Market Worth USD 23.3 Billion by 2024
Siemens Publicly Lists Healthcare Business
Thermo Fisher Scientific and Hamilton Partner to Offer Storage Solutions
Autoimmune Industry Characterized by High Demand and Competition
Chembio Diagnostics Announces Two New Senior-Level Appointments
Founder of Quantimetrix Dies at 89
Middle East In Vitro Diagnostics Market Worth USD3.4 Billion by 2021
Danaher Corporation to Acquire Phenomenex
Instrumentation Laboratory Acquires CA Casyso
Danaher to Acquire Cepheid for USD 4 Billion
Global In Vitro Diagnostic Test Market Worth USD 60 Billion
Critical Care Diagnostics Market Worth USD 1.29 Billion By 2024
LabCorp to Acquire Sequenom
Global Digital Pathology Market Worth USD 1,052 Million by 2022
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.